Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Anne M. Noonan, Matthew R. Farren, Susan M. Geyer, Ying Huang, Sanaa Tahiri, Daniel Ahn, Sameh Mikhail, Kristen K. Ciombor, Shubham Pant, Santiago Aparo, Jennifer Sexton, John L. Marshall, Thomas A. Mace, Christina S. Wu, Bassel El-Rayes, Cynthia D. Timmers, James Zwiebel, Gregory B. Lesinski, Miguel A. Villalona-Calero, Tanios S. Bekaii-Saab

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds